Raising Awareness, Driving Action

This past year was an exciting and consequential time in the fight against Alzheimer's Disease. Read more about our efforts in this year's Annual Report.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

The Brain Health Academy

Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s. Next Session: Sleep and Dementia, August 17

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

The fight to end Alzheimer’s got a major boost today as the U.S. House Appropriations Committee passed significant funding increases for Alzheimer’s research, prevention, and treatment.

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s chair and co-founder George Vradenburg submitted public comment to Centers for Medicare and Medicare Services (CMS) urging the agency to reconsider their National Coverage Determination (NCD) and provide coverage without CED for the FDA-approved use of amyloid-beta PET scan.

New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.

The 2021 Annual Report

Say Hello to BrainGuide

The Brain Health Academy

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • December 22, 2021

    Letter to Becerra: Historic Medicare Premium Increase Must be Reversed Based on New Data

    UsAgainstAlzheimer’s, a patient advocacy group representing more than six million Alzheimer’s patients...

    Read more
  • December 20, 2021

    Dramatic Price Reduction for Aduhelm Gives Hope to Alzheimer’s Patients

    More patients will soon have access to Aduhelm, the only treatment on...

    Read more
  • December 17, 2021

    European Medicines Agency Blocks Treatment for Alzheimer’s Patients

    The European Medicines Agency (EMA) today delivered an unconscionable blow to Alzheimer’s...

    Read more
  • December 17, 2021

    Read Full Article

    Early Descriptions of Family Caregivers' Experiences With Unexpected Lucidity

    Innovations in Aging, December 2021

    Read more
  • December 16, 2021

    UsAgainstAlzheimer’s Applauds Biogen for Speeding up Follow-up Trials for Aduhelm

    The company that manufactures Aduhelm, the only treatment on the market that...

    Read more
  • Greg O'Brien

    Congress Should Act: Paid Leave for Caregivers Essential in the Battle with Dementia

    “I got plenty of money; it’s just tied up in debt,” as...

    Read more

Reports

  • Resources

    A-LIST Pulse of the Community - December 2021

  • Resources

    2020 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2020. 

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...